Cytokinetics Aktie
49,03
EUR
+0,89
EUR
+1,85
%
55,12
USD
+1,43
USD
+2,66
%
Erwachsen handeln.
Mit dem Broker, der Top-Insights, geprüfte Analysen
und Trading ab 0 € vereint (zzgl. Spreads).
Werbung
Cytokinetics Aktie Analyse
| 21.09.18 | Cytokinetics Overweight | Cantor Fitzgerald | |
| 22.11.17 | Cytokinetics Buy | Needham & Company, LLC | |
| 21.11.17 | Cytokinetics Buy | H.C. Wainwright & Co. | |
| 08.03.17 | Cytokinetics Buy | Rodman & Renshaw, LLC | |
| 06.02.17 | Cytokinetics Strong Buy | Needham & Company, LLC | |
| 16.12.16 | Cytokinetics Overweight | Cantor Fitzgerald | |
| 10.11.15 | Cytokinetics Outperform | FBR Capital | |
| 09.11.15 | Cytokinetics Buy | ROTH Capital Partners, LLC | |
|
Werbung
|
|||
| 24.07.15 | Cytokinetics Buy | MLV Capital | |
| 31.12.14 | Cytokinetics Buy | ROTH Capital Partners, LLC | |
| 04.11.14 | Cytokinetics Buy | MLV Capital | |
| 03.07.12 | Cytokinetics buy | Needham & Company, LLC | |
| 20.05.08 | Cytokinetics | Global Biotech Investing | |
Werbung
Werbung